Shukra Pharmaceuticals Ltd: AGM Approves Financials and Dividend

Shukra Pharmaceuticals Ltd held its 33rd Annual General Meeting (AGM) on September 28, 2026, via video conferencing. All resolutions presented, including the adoption of the Audited Financial Statements for the fiscal year ended March 31, 2026, and the declaration of the final dividend for FY 2025-26, were passed. The re-appointment of Ms. Sanskruti Patel as a Director was also approved. The company reported strong voting results, with resolutions passing with overwhelming support. The detailed voting results and the Scrutinizer's Report are available on the company's website.